Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: Novo holdings | Rare Historical Photos

Catalent Stock: Is CTLT Outperforming the Healthcare Sector?

Despite Catalent’s outperformance relative to the broader sector, Wall Street analysts remain cautious about the stock’s prospects.

Barchart · Sep 26, 2024

What to Expect From Catalent's Q4 2024 Earnings Report

Catalent will unveil its Q4 earnings in September, and analysts project a triple-digit bottom-line growth.

Barchart · Jul 30, 2024

Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs

Despite concerns over its ability to meet surging semaglutide demand, this Danish pharmaceutical giant holds a dominant position in the diabetes and insulin markets - and now commands the lead in Europe's stock market, too. Here's why NVO is a must-own stock.

Barchart · Feb 16, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Novo Holdings Acquires Catalent for .5 Billion, Expands Wegovy Capacity

Novo Holdings has announced its acquisition of Catalent for .5 billion, a move aimed at expanding the production capacity of Wegovy, a drug used for obe...

Roslin Technologies closes £11 million Series A funding round

The money will be used to scale up production in line with the growing cultivated meat sector

Insider UK · Nov 3, 2022

PwC advised on business deals in Wales with a value £700m in 2021

A major deal included the acquisition of Caerphilly-based BBI Solutions by Danish firm Novo Holdings

Birmingham Post · Feb 11, 2022

Coverage From

Organisations

University of Edinburgh

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.